Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma.
about
Practical approaches to the use of lenalidomide in multiple myeloma: a canadian consensus.Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation.Challenges in multiple myeloma diagnosis and treatment.Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma.Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation.Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
P2860
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lenalidomide plus dexamethason ...... wly diagnosed elderly myeloma.
@ast
Lenalidomide plus dexamethason ...... wly diagnosed elderly myeloma.
@en
type
label
Lenalidomide plus dexamethason ...... wly diagnosed elderly myeloma.
@ast
Lenalidomide plus dexamethason ...... wly diagnosed elderly myeloma.
@en
prefLabel
Lenalidomide plus dexamethason ...... wly diagnosed elderly myeloma.
@ast
Lenalidomide plus dexamethason ...... wly diagnosed elderly myeloma.
@en
P2093
P50
P1476
Lenalidomide plus dexamethason ...... wly diagnosed elderly myeloma.
@en
P2093
A Keith Stewart
Francesca Gay
Maria Teresa Petrucci
Mario Boccadoro
Patrizia Falco
Shaji Kumar
P304
P356
10.1111/J.1600-0609.2010.01469.X
P577
2010-05-08T00:00:00Z